Cited by 19Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and LipoproteinsAcute Myocardial Infarction Research

Remnant cholesterol and long-term incidence of death in coronary artery disease patients

Open access
Drexel, Heinz, Mader, Arthur, Larcher, Barbara, Festa, Andreas, Vonbank, Alexander, Fraunberger, Peter, Leiherer, Andreas, Saely, Christoph H.·2025·Atherosclerosis

Abstract

Background Remnant cholesterol (RC), defined as non-HDL-non-LDL cholesterol, has attracted recent scientific interest as a candidate lipid factor for residual cardiovascular risk. Despite a rising amount of epidemiologic information, there are imprecisions because most available data arise from non-fasting, frozen and calculated values. Methods We enrolled 1474 consecutive patients with angiographically proven CAD, and measured RC in strictly fasting, non-frozen samples with a direct assay for LDL-C. Prospectively, all-cause mortality, cardiovascular mortality, and major adverse cardiovascular events (MACE) were recorded over a mean follow-up period of 11.6 ± 5.0 years, covering 17098 patient years. Results During follow-up, CAD patients had a rate of all-cause mortality of 52.2 % (n = 769), of cardiovascular mortality of 20.6 % (n = 303), and an incidence of major adverse cardiovascular events (MACE) of 39.1 % (n = 576). Prospectively, RC was associated with all-cause mortality (HR 1.12 [1.03-1.23], p = 0.009), cardiovascular mortality (HR 1.20 [1.06-1.36], p = 0.005), and MACE (HR 1.10 [1.01-1.21], p = 0.033) in Cox regression analyses across various levels of adjustment (age, sex, smoking, LDL-C, HDL-C, hypertension, T2DM, and BMI). Findings did not differ between women and men. Furthermore, there was no discernible influence of statin treatment. Conclusions From our data we conclude that RC is associated with future all-cause mortality, cardiovascular mortality and MACE i…

Integrity signals

Registry

Crossref · 10.1016/j.atherosclerosis.2024.119048

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Observational cohorts demonstrate that higher TG and remnant cholesterol predict cardiovascular events independently of LDL-C.

    “Observational cohorts demonstrate that higher TG and remnant cholesterol predict cardiovascular events independently of LDL-C, while Mendelian randomization analyses confirm a causal relationship between lifelong TRL elevation and ASCVD.”

    From Targeting triglycerides for cardiovascular risk reduction (2026) · cites this paper as [41]

Cites

Flagged first, then by citations

1 of the 54 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Drexel, H., Mader, A., Larcher, B., Festa, A., Vonbank, A., Fraunberger, P., Leiherer, A., & Saely, C. H.
Affiliations
  • Private University in the Principality of Liechtenstein (LI)
  • Landeskrankenhaus Feldkirch (AT)
Corresponding author
Drexel, Heinz
Venue
Atherosclerosis
Publisher
Elsevier BV
Published
2025-02
Volume
401
Pages
119048
ISSN
0021-9150 (ISSN-L)
OpenAlex
W4404437443
Cited by
17
References
54
Citations by year
2026: 9 · 2025: 8
FWCI
7.12
Type
journal article
Language
en
Open access
Locations
  • Atherosclerosis (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
Keywords
remnant cholesterol, coronary artery disease, all-cause mortality, cardiovascular mortality, major adverse cardiovascular events, residual cardiovascular risk, non-HDL cholesterol, LDL cholesterol, statin therapy, long-term prognosis
MeSH terms
Aged, Cause of Death, Cholesterol, Coronary Artery Disease, Female, Humans, Lipoproteins, Cholesterol, LDL, Male, Middle Aged, Prospective Studies, Risk Factors, Time Factors, Triglycerides, Biomarkers, Incidence, Proportional Hazards Models, Coronary Angiography, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review